There's something here that will cure what ails you. Photographer: Niccolo Guasti/Getty Images

Trade of the Day: A Hedge Against Narcolepsy

Mark Gilbert is a Bloomberg Gadfly columnist covering asset management. He previously was a Bloomberg View columnist, and prior to that the London bureau chief for Bloomberg News. He is the author of “Complicit: How Greed and Collusion Made the Credit Crisis Unstoppable.”
Read More.
a | A

In recent years, drugmakers have raised prices on dozens of brand-name medicines at a pace that outstrips inflation, Bloomberg News reportstoday. The accompanying graphic shows that the cost of one drug in particular -- Xyrem, a narcolepsy treatment from Jazz Pharmaceuticals -- has climbed more than 840 percent since 2007.

So the Trade of the Day is to buy Xyrem and stockpile it in your medicine cabinet -- just in case.

This column does not necessarily reflect the opinion of Bloomberg View's editorial board or Bloomberg LP, its owners and investors.

To contact the author on this story:
Mark Gilbert at

To contact the editor on this story:
James Greiff at